New Highs: Exactech (NASDAQ:EXAC), Pain Therapeutics (NASDAQ:PTIE), Sagent Pharmaceuticals (NASDAQ:SGNT), CIGNA (NYSE:CI), Hologic (NASDAQ:HOLX)

Exactech, Inc. (NASDAQ:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced its slate of products to be featured at the company’s technical exhibit, Capital Hall, Booth #16, at the 15th Annual Congress of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT) June 4-6 in London. Exactech, Inc. (NASDAQ:EXAC) net profit margin is 6.50% and weekly performance is 1.61%. On last trading day company shares ended up $25.23. Analysts mean target price for the company is $28.75. Exactech, Inc. (NASDAQ:EXAC) distance from 50-day simple moving average is 9.44%.

Pain Therapeutics (NASDAQ:PTIE) last released its earnings data on Tuesday, May 6th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.02. During the same quarter in the previous year, the company posted ($0.01) earnings per share. Analysts expect that Pain Therapeutics will post $-0.30 EPS for the current fiscal year.Pain Therapeutics, Inc. (NASDAQ:PTIE) shares advanced 3.00% in last trading session and ended the day on $5.84. PTIE its return on assets is 56.10%. Pain Therapeutics, Inc. (NASDAQ:PTIE) quarterly performance is 10.19%.

Sagent Pharmaceuticals (NASDAQ:SGNT) Director Robert J. Flanagan sold 16,000 shares of Sagent Pharmaceuticals stock on the open market in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $23.37, for a total value of $373,920.00. Following the completion of the sale, the director now directly owns 6,996 shares in the company, valued at approximately $163,497. Sagent Pharmaceuticals Inc (NASDAQ:SGNT) shares moved up 3.95% in last trading session and was closed at $25.51, while trading in range of $25.41-$26.23. Sagent Pharmaceuticals Inc (NASDAQ:SGNT) year to date performance is 0.51%.

CIGNA Corporation (NYSE:CI) welcomed over 100 new customer service employees at a ribbon-cutting opening the company’s new health care call center in North Fayette, as service associates at the new call center began taking customer calls. Fifty more customer service personnel will be hired by year-end. CIGNA Corporation (NYSE:CI) ended the last trading day at $92.11. Company weekly volatility is calculated as 1.40% and price to cash ratio as 10.87. CIGNA Corporation (NYSE:CI) showed a positive weekly performance of 1.69%.

Hologic, Inc. (HOLX) reported positive results from a study validating the company’s 3D Mammography (breast tomosynthesis) screening technology. Per the study, Hologic’s 3D mammography leads to more efficient and accurate detection of invasive breast cancers, compared to a traditional mammogram.Hologic, Inc. (NASDAQ:HOLX) net profit margin is -46.10% and weekly performance is 1.07%. On last trading day company shares ended up $25.60. Analysts mean target price for the company is $23.59. Hologic, Inc. (NASDAQ:HOLX) distance from 50-day simple moving average is 8.91%.